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Summary
INTRODUCTION: Acquired syphilis has re-emerged in
many Western European countries. In contrast to interna-
tional guidelines, screening for syphilis in pregnancy is not
generally recommended in Switzerland. There has been an
increase in the incidence of laboratory syphilis notifica-
tions in recent years, regardless of gender and age.
METHODS: We conducted a retrospective study, evalu-
ating the total numbers of pregnant women with positive
syphilis serology (Treponema pallidum Particle Agglutin-
ation assay, TPPA) from 2000 to 2009, and evaluated the
clinical management and outcome of their offspring. In ad-
dition, we sought to determine cases of infectious syphil-
is (primary, secondary, and early latent syphilis) reported
to the Swiss Federal Office of Public Health in women of
childbearing age, which has previously been shown to pre-
cede changes in the incidence of congenital syphilis within
a population.
RESULTS: Out of 13,833 women who gave birth at our in-
stitution, positive syphilis serology was found in 9 pregnant
women during the 10 years studied. A total of 6 pregnant
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women were diagnosed having syphilis infection during
pregnancy. Regarding their offspring, 8 of the 9 newborns
were tested serologically. One neonate experienced con-
genital syphilis because the adequately treated mother de-
veloped re-infection after treatment. Within the Swiss pop-
ulation, infectious syphilis cases in women of childbearing
age increased substantially from 2006 to 2009.
CONCLUSIONS: The epidemiologic data suggest that
congenital syphilis could become a medical problem in
Switzerland due to the rise of infectious syphilis cases in
women of childbearing age that have been shown to be fol-
lowed by changes in the congenital syphilis incidence. The
persistence of congenital syphilis in Switzerland along with
this rise of infectious syphilis in women of childbearing age
suggests a potential for improvement of prenatal care and
syphilis control programmes.
Key words: congenital syphilis; disease management;
pregnancy; screening; newborn
Introduction
Syphilis is a sexually acquired infection caused by the spir-
ochete Treponema pallidum. Many people with syphilis
have unrecognised disease. Thus, transmission may occur
from persons who are unaware of their infection [1]. As a
separate entity, congenital syphilis (CS) is a serious condi-
tion [2]: it is associated with miscarriage, stillbirth, foetal
abnormalities, and prematurity. Babies born with syphilis
develop either an early symptomatic disease (early CS) or
may be asymptomatic at birth developing serious problems
later (late CS).
In Western Europe, the incidence of syphilis has been in-
creasing since the late nineties [3]. Switzerland has two dis-
tinctive features regarding syphilis surveillance: first, syph-
ilis was removed from the list of notifiable sexually trans-
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missed diseases (STIs) in 1999 due to decreasing incidence
rates but was re-included in 2006 due to recognition of
rising rates of disease [4–6]. Second, syphilis screening on
a regular basis during pregnancy was stopped during the
1990s and has not been routinely performed since that time
[7]. This is in contrast to worldwide guidelines and the
course of action of almost every nation in the world [8, 9].
We aimed to assess recent trends of syphilis cases in preg-
nant women and neonates in Switzerland. Therefore, we
analysed data between 2000 and 2009 from a large urban
hospital to evaluate the total numbers of pregnant women
tested seropositive for syphilis, and the clinical manage-
ment and outcome of the neonates born to these mothers. In
addition, we reviewed national surveillance data from re-
cent years captured by the Swiss Federal Office of Public
Health (SFOPH) in order to assess infectious syphilis cases
in women of childbearing age, as changes in this meas-
urement have been previously shown to precede similar
changes in the incidence of CS [10].
Methods
In Zurich, the Triemli Hospital Zurich is an urban hospital
with approximately the seventh largest maternity unit in
Switzerland providing increasing numbers of live births
(from 1,246 in 2000 to 1,654 in 2009). In all pregnant
women who gave birth in Triemli Hospital Zurich, those
with conducted syphilis serology were further analysed and
only cases with a positive serology were included in the
study. Women were defined as seropositive if the T. pal-
lidum Particle Agglutination assay (TPPA) was positive at
any time during pregnancy. In most cases in which TPPA
was positive, the Veneral Disease Research Laboratory test
(VDRL), the Fluorescent Treponemal Antibody-Absorp-
tion test (FTA-ABS), and an IgM enzyme immunoassay
(EIA) test (Pathozyme Syphilis M Capture) were per-
formed. We evaluated the clinical management and ana-
lysed the outcome of the neonates born to these mothers
by review of the patient’s medical records. The study was
approved by the ethics committee of Zurich (Study No.
2009-0050/0).
In Switzerland, since 2006, all syphilis cases have to be re-
ported to the SFOPH by laboratories and attending clini-
cians. Each case is classified by the SFOPH according to
the supporting clinical information, which means that cases
cannot be classified if this information is missing or incom-
plete. Out of this database, we were especially interested in
the numbers of confirmed infectious syphilis cases among
women in the childbearing age group (20–44 years) for the
years 2006 to 2009.
Results
During the study period, 13,833 women delivered 13,968
infants (135 twins). A positive syphilis serology was found
in 9 pregnant women giving birth to 9 children (fig. 1) with
the following distribution: 2000: 1 (case), 2001: 1, 2002: 2,
2005: 1, 2006: 1, 2009: 3 (data not shown). Out of these
9 women, 6 were newly diagnosed in pregnancy: 5 were
found to have active or latent syphilis (re-)infection and re-
ceived antibiotic treatment, and 1 residual antibody titre of
a past infection (Appendix 1). A total of 8 of the 9 women
were immigrants.
Regarding their offspring, 8 of the 9 newborns were tested
serologically after birth (fig. 1). The results showed a total
of 5 children with positive TPPA at birth, negative IgM an-
tibodies, and no signs of CS, and 1 case of symptomatic CS
together with a high positive IgM antibody concentration
(Appendix 2). In 2 of the newborns of adequately treated
mothers, a single dose of penicillin IM was administered
directly after birth.
Within the SFOPH database, nearly 75% of confirmed
cases in females were found in 20–44 year old women,
which is the age group accounting for almost 99% of all
births in Switzerland. Including only cases classified as be-
ing infectious (primary, secondary, and early latent syph-
ilis), numbers in this age group increased from 8 cases in
2006 to 31 cases in 2009 (fig. 2).
Discussion
Recent data show an increasing syphilis incidence in other
developed and newly industrialised countries [10, 11].
Since 2006, syphilis is clearly re-emerging also in Switzer-
land [4–6]. The reported cases are amongst the highest in
Western Europe [12] with a parallel increase of other STIs
[4–6, 13], also as a consequence of a better notification
compliance. Along with the rise of reported syphilis cases,
infectious syphilis in women of childbearing age increased
substantially from 2006 to 2009 (fig. 2), which implies that
a substantial proportion of syphilis testing is performed as
part of the prenatal screening. The increasing numbers of
infected women is worrisome and suggests either novel
sexual networks, a change in sexual behaviour or an in-
creased “heterosexual bridging” from contacts with men
who have sex with men (MSM) [14]. Although true incid-
ences cannot be calculated through the current notification
approach, both the numbers themselves as well as the trend
of reported cases suggest an increase in syphilis cases in all
ages and both sexes in Switzerland [6]. As changes in the
population incidence have been shown to be followed by
Figure 2
Confirmed infectious syphilis cases among women aged 20–44
years (childbearing age group), 2006–2009 (in red), together with
total numbers of laboratory syphilis notification in Switzerland,
1988–2009 (adapted from [5, 6]).
1988–1999: laboratory notifications (Swiss Sentinel Network on
STIs);
2000–2005: data not reported for syphilis;
Since 2006: laboratory and clinical notifications (SFOPH and
attending physicians).
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similar changes in the CS incidence [10, 11, 15], the epi-
demiologic data suggest increasing numbers of CS cases in
Switzerland. Although CS numbers were low throughout
the whole study period, we found 1 case of symptomatic
CS together with a peak of 3 syphilis seropositive pregnant
women in 2009.
CS is a preventable disease and syphilis pregnancy screen-
ing is an effective measure, both for prevention of the dis-
ease as well as for treating pregnant women and their part-
ners [14, 16–18]. The most important risk factor for CS is
inadequate prenatal care with an associated lack of syphil-
is screening [11]. Therefore, the WHO recommends that all
pregnant women should be screened for syphilis in preg-
nancy mainly because of the asymptomatic latent stage of
the disease [8]. In Europe, TPPA and TPHA are established
as a screening test, with EIA as an alternative [19, 20]. The
screening should be done at the first antenatal visit and po-
tentially repeated in the third trimester of pregnancy, and
every not yet screened woman must be screened immedi-
ately at or after birth [8, 14, 21, 22]. Diagnosis and manage-
ment of maternal syphilis is complex, leading to uncertain-
ties and time-consuming discussions amongst clinicians.
Usually, at least 3 to 4 clinical disciplines are involved
(obstetricians, paediatricians, infectious disease specialists,
and dermatologists). This complexity is reflected by the
fact that we found a great disparity in the management
of mothers with a positive syphilis serology and their off-
spring in our study cohort.
As most of the syphilis screening serologies are performed
in private practice in Switzerland and are not documented
in the hospital notes, we were not able to retrieve the total
number of serologies obtained during the study period,
which would have enabled us to calculate sero-prevalen-
ces. It is conceivable that in our study some CS cases re-
mained undetected and untreated, simply because (1) preg-
nancy screening was done externally but women gave birth
in the study hospital, (2) due to false-negative screening
serologies performed in an early stage of disease, or (3) be-
cause there was no serology performed at all. Even symp-
tomatic cases of CS might have been undetected because
this disease often presents with unspecific clinical signs.
Therefore, the number of seropositive mothers detected in
our hospital during the study period is a very conservative
estimate and might be underestimated.
Conclusion
Although our study shows only one case of (true) CS, the
epidemiologic data suggest more cases due to the rise of in-
fectious syphilis cases in women of childbearing age that
have been shown to be followed by changes in the CS in-
cidence within a population. The findings presented in our
Figure 1
Antenatal syphilis serology, Triemli Hospital Zurich, 2000–2009.
1 Adequate treatment: documented treatment with a penicillin regimen according to current guidelines, and completed ≥4 weeks prior to
delivery, and no evidence of treatment failure (as might be suggested, e.g., by unchanged or increasing VDRL titers), and no evidence of
syphilis re-infection or relapse.
2 Inadequate treatment: no treatment, no documentation of treatment, treated with a non-penicillin regimen, evidence for treatment failure or
treatment completed <4 weeks prior to delivery.
3 One newborn tested only with IgM EIA and without TPPA.
4 Symptomatic disease with IgM EIA test positive and abnormal placental exam (Appendix 2).
5 All parts of the infant’s evaluation normal and in 7 of 8 newborns negative syphilis serology (IgM test negative, VDRL <4-fold than maternal
VDRL, and placental exam negative (if performed)) (Appendix 1).
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study should guide public health professionals in planning
surveillance and target preventive campaigns, for example
by a prospective screening study in several large maternity
units in Switzerland and an introduction of a surveillance
system for CS by the Swiss Paediatric Surveillance Un-
it (SPSU). The persistence of CS in Switzerland suggests
a potential for improvement of prenatal care and syphilis
control programmes.
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Appendix 1
Characteristics of syphilis seropositive mothers and their
infants in pregnancy and at follow-up examination, Triemli
Hospital Zurich, 2000–2009.
Appendix 2
Case report of the neonate with congenital syphilis.
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Figures (large format)
Figure 1
Antenatal syphilis serology, Triemli Hospital Zurich, 2000–2009.
1 Adequate treatment: documented treatment with a penicillin regimen according to current guidelines, and completed ≥4 weeks prior to delivery,
and no evidence of treatment failure (as might be suggested, e.g., by unchanged or increasing VDRL titers), and no evidence of syphilis re-
infection or relapse.
2 Inadequate treatment: no treatment, no documentation of treatment, treated with a non-penicillin regimen, evidence for treatment failure or
treatment completed <4 weeks prior to delivery.
3 One newborn tested only with IgM EIA and without TPPA.
4 Symptomatic disease with IgM EIA test positive and abnormal placental exam (Appendix 2).
5 All parts of the infant’s evaluation normal and in 7 of 8 newborns negative syphilis serology (IgM test negative, VDRL <4-fold than maternal
VDRL, and placental exam negative (if performed)) (Appendix 1).
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Figure 2
Confirmed infectious syphilis cases among women aged 20–44 years (childbearing age group), 2006–2009 (in red), together with total numbers
of laboratory syphilis notification in Switzerland, 1988–2009 (adapted from [5, 6]).
1988–1999: laboratory notifications (Swiss Sentinel Network on STIs);
2000–2005: data not reported for syphilis;
Since 2006: laboratory and clinical notifications (SFOPH and attending physicians).
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